Showing metabocard for Pyrromycin (MMDBc0060809)
Microbial
| Record Information | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 2.0 | |||||||||||||||
| Status | Detected and Quantified | |||||||||||||||
| Creation Date | 2025-10-02 23:26:09 UTC | |||||||||||||||
| Update Date | 2025-10-08 21:35:22 UTC | |||||||||||||||
| Metabolite ID | MMDBc0060809 | |||||||||||||||
| Metabolite Identification | ||||||||||||||||
| Common Name | Pyrromycin | |||||||||||||||
| Description | Pyrromycin is a member of the anthracycline chemical class, characterized by a tetracyclic ring structure that is typical of this group. Its chemical structure features a glycosidic bond, which is crucial for its biological activity. Pyrromycin has been identified as a metabolite produced by certain microbial isolates, alongside other compounds like doxorubicinol and erythromycin (PMID:29720968 ). In various studies, pyrromycin has been shown to interact with DNA methyltransferases (DNMTs), indicating its potential role in epigenetic regulation (PMID:26099696 ). High-throughput screening has highlighted pyrromycin as an upregulator of ABCA1 expression, suggesting involvement in lipid metabolism pathways (PMID:18594022 ). Additionally, its growth-inhibitory effects have been compared with other anthracyclines in both resistant and wild-type cell lines, revealing its potency against cancer cells (PMID:8422694 ). Furthermore, pyrromycin has been implicated in stimulating erythroid differentiation and hemoglobin synthesis in specific cell lines, distinguishing it from other anthracyclines that do not exhibit this effect (PMID:2020200 ). Overall, pyrromycin's unique structural features and biological activities contribute to its significance in the field of medicinal chemistry. | |||||||||||||||
| Structure |  | |||||||||||||||
| Synonyms | Not Available | |||||||||||||||
| Molecular Formula | C30H35NO11 | |||||||||||||||
| Average Mass | 585.606 | |||||||||||||||
| Monoisotopic Mass | 585.221010951 | |||||||||||||||
| IUPAC Name | Not Available | |||||||||||||||
| Traditional Name | Not Available | |||||||||||||||
| CAS Registry Number | Not Available | |||||||||||||||
| SMILES | Not Available | |||||||||||||||
| InChI Identifier | Not Available | |||||||||||||||
| InChI Key | ZJBMQVPEJHVSQA-OCYVVMCSSA-N | |||||||||||||||
| Chemical Taxonomy | ||||||||||||||||
| Description | Belongs to the class of organic compounds known as anthracyclines. These are polyketides containing a tetracenequinone ring structure with a sugar attached by glycosidic linkage. | |||||||||||||||
| Kingdom | Organic compounds | |||||||||||||||
| Super Class | Phenylpropanoids and polyketides | |||||||||||||||
| Class | Anthracyclines | |||||||||||||||
| Sub Class | Not Available | |||||||||||||||
| Direct Parent | Anthracyclines | |||||||||||||||
| Alternative Parents |
| |||||||||||||||
| Substituents |
| |||||||||||||||
| Molecular Framework | Aromatic heteropolycyclic compounds | |||||||||||||||
| External Descriptors | Not Available | |||||||||||||||
| Functional Ontology | ||||||||||||||||
| Not Available | ||||||||||||||||
| Physical Properties | ||||||||||||||||
| State | Not Available | |||||||||||||||
| Predicted Properties | Not Available | |||||||||||||||
| Spectra | ||||||||||||||||
| Not Available | ||||||||||||||||
| Chromatographic Retention Times and Retention Indices | ||||||||||||||||
| Retention Times | Not Available | |||||||||||||||
| Retention Indices | Not Available | |||||||||||||||
| Biological Properties | ||||||||||||||||
| Cellular Locations | Not Available | |||||||||||||||
| Biospecimen Locations | Not Available | |||||||||||||||
| Tissue Locations | Not Available | |||||||||||||||
| Associated OMIM IDs | ||||||||||||||||
| Human Proteins and Enzymes | ||||||||||||||||
| ||||||||||||||||
| Human Pathways | ||||||||||||||||
| Pathways |
| |||||||||||||||
| Microbial Pathways | ||||||||||||||||
| Pathways | Not Available | |||||||||||||||
| Metabolic Reactions | ||||||||||||||||
Reactions This table shows at most 20 reactions. For the full list of associated reactions: See All Associated Reactions
| ||||||||||||||||
| Health Effects and Bioactivity | ||||||||||||||||
| ||||||||||||||||
| Microbial Sources | ||||||||||||||||
| ||||||||||||||||
| Exposure Sources | ||||||||||||||||
| Other Exposures |
| |||||||||||||||
| Host Biospecimen and Location | ||||||||||||||||
| ||||||||||||||||
| External Links | ||||||||||||||||
| HMDB ID | Not Available | |||||||||||||||
| DrugBank ID | Not Available | |||||||||||||||
| Phenol Explorer Compound ID | Not Available | |||||||||||||||
| FooDB ID | Not Available | |||||||||||||||
| KNApSAcK ID | Not Available | |||||||||||||||
| Chemspider ID | Not Available | |||||||||||||||
| KEGG Compound ID | Not Available | |||||||||||||||
| BioCyc ID | Not Available | |||||||||||||||
| BiGG ID | Not Available | |||||||||||||||
| Wikipedia Link | Not Available | |||||||||||||||
| METLIN ID | Not Available | |||||||||||||||
| PubChem Compound | 196990 | |||||||||||||||
| PDB ID | Not Available | |||||||||||||||
| ChEBI ID | Not Available | |||||||||||||||
| Food Biomarker Ontology | Not Available | |||||||||||||||
| CMMC Knowledgebase | ZJBMQVPEJHVSQA-OCYVVMCSSA-N | |||||||||||||||
| General References | ||||||||||||||||
| ||||||||||||||||
